Jafar Rezaie

5.0k citations
92 papers · 3.9k indexed · 3 hit papers · h-index 37
    • MicroRNA in disease regulation 37
    • Cancer-related molecular mechanisms research 6
    • Extracellular vesicles in disease 49
    • RNA Interference and Gene Delivery 16
    • Circular RNAs in diseases 15
  • Genetics top 5%
    • Mesenchymal stem cell research 5
  • Immunology top 10%
    • Electrospun Nanofibers in Biomedical Applications 4
    • Autophagy in Disease and Therapy 7

Jafar Rezaie

88 papers receiving 3.9k citations

Hit Papers

A review on exosomes application in clinical trials: pers...4242020202620222024100200300400

Peers

Jafar Rezaie
Comparison fields: 5 of 123
  • Cancer Research 1.8k
  • Molecular Biology 3.1k
  • Genetics 314
  • Immunology 412
  • Biomaterials 240
Replace Oscar P. B. Wiklander with:
Oscar P. B. Wiklander Sweden
Yue Wang China
Nicoletta Zini Italy
Sweta Rani Ireland
Susmita Sahoo United States
Yingying Jing China
Ke Huang China
Xuan Wang China
Shengfang Ge China
Yan Zhuang China
Jafar Rezaie relative to Oscar P. B. Wiklander Sweden Oscar P. B. Wiklander's profile →
Citations per field
00.5×1.6×
Oscar P. B. Wiklander · 1×
Citations per year

Countries citing papers authored by Jafar Rezaie

Since Specialization
Citations

This map shows the geographic impact of Jafar Rezaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jafar Rezaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jafar Rezaie more than expected).

Fields of papers citing papers by Jafar Rezaie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jafar Rezaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jafar Rezaie. The network helps show where Jafar Rezaie may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jafar Rezaie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jafar Rezaie Line = papers co-authored together Jafar Rezaie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20247
3 20240
4 20234
5 20237
6 20232
7 20237
8 202223
9 202250
10 20226
11 202220
12 202119
13 202136
14 20214
15 202050
16 20209
17 202030
18 2020112
19 2020114
20 201953

About Jafar Rezaie

Jafar Rezaie is a scholar working on Cancer Research, Molecular Biology and Biomaterials, having authored 92 papers that have together received 3.9k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (49 papers), MicroRNA in disease regulation (37 papers), RNA Interference and Gene Delivery (16 papers), Circular RNAs in diseases (15 papers), Autophagy in Disease and Therapy (7 papers), Cancer-related molecular mechanisms research (6 papers), Mesenchymal stem cell research (5 papers) and Electrospun Nanofibers in Biomedical Applications (4 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (3.1k citations) and Genetics (314 citations). Jafar Rezaie has collaborated with scholars based in Iran, United States and Türkiye. Frequent co-authors include Mahdi Ahmadi, Maryam Feghhi, Tahereh Etemadi, Reza Rahbarghazi‬, Reza Jafari, Ali Akbari, Mehdi Hassanpour, Sepideh Nikfarjam, Nasrollah Jabbari and Naime Majidi Zolbanin. Their work appears in journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026